Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Asset Utilization Ratio (2018 - 2025)

Crinetics Pharmaceuticals has reported Asset Utilization Ratio over the past 8 years, most recently at 0.01 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.01 for Q4 2025, up 656.56% from a year ago — trailing twelve months through Dec 2025 was 0.01 (up 656.56% YoY), and the annual figure for FY2025 was 0.01, up 498.72%.
  • Asset Utilization Ratio for Q4 2025 was 0.01 at Crinetics Pharmaceuticals, up from 0.0 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for CRNX hit a ceiling of 0.02 in Q2 2023 and a floor of 0.0 in Q1 2025.
  • Median Asset Utilization Ratio over the past 5 years was 0.01 (2023), compared with a mean of 0.01.
  • Biggest five-year swings in Asset Utilization Ratio: surged 939.79% in 2021 and later tumbled 90.91% in 2024.
  • Crinetics Pharmaceuticals' Asset Utilization Ratio stood at 0.0 in 2021, then surged by 234.09% to 0.01 in 2022, then crashed by 51.1% to 0.01 in 2023, then crashed by 86.06% to 0.0 in 2024, then surged by 656.56% to 0.01 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.01 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q2 2025) per Business Quant data.